Full Text View
Tabular View
No Study Results Posted
Related Studies
Anakinra in Treating Patients With Metastatic Cancer Expressing the Interleukin-1 Gene
This study has been completed.
Study NCT00072111   Information provided by National Cancer Institute (NCI)
First Received: November 4, 2003   Last Updated: February 6, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Interventions listed in this trial
anakinra
Additional drug interventions recognized in this trial
Interleukin 1 Receptor Antagonist Protein
More general drug interventions related to this trial
Antirheumatic Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
National Cancer Institute (NCI)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services